Financhill
Back

Pfizer Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

PFE
Pfizer

Last Price:
28.50
Seasonality Move:
4.27%
Sell
37

SRPT
Sarepta Therapeutics

Last Price:
128.74
Seasonality Move:
5.72%
Sell
23
Pfizer (PFE) is a Sell

Is Pfizer a Buy, Sell or Hold?

  • The current Pfizer [PFE] share price is $28.56. The Score for PFE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $128.96. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PFE Stock Price Chart

What is Pfizer's stock price today?

  • The Pfizer share price today is $28.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFE is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $128.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

PFE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 44.95 Sell
Chaikin Money Flow: 4448318 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.41 - 29.29) Sell
Bollinger Bands (100): (27.13 - 29.61) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.97 Sell
Relative Strength Index (14 RSI): 33.42 Sell
Chaikin Money Flow: -442878 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (132.05 - 141.57) Sell
Bollinger Bands (100): (123.25 - 147.73) Sell

PFE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.63 Sell
20-day SMA: 28.71 Sell
50-day SMA: 29.04 Sell
200-day SMA: 28.15 Buy
8-day EMA: 28.61 Sell
20-day EMA: 28.8 Sell
50-day EMA: 28.84 Sell
200-day EMA: 29.48 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 135.65 Sell
20-day SMA: 135.81 Sell
50-day SMA: 143.04 Sell
200-day SMA: 124.45 Buy
8-day EMA: 134.62 Sell
20-day EMA: 136.91 Sell
50-day EMA: 138.29 Sell
200-day EMA: 129.11 Sell

Pfizer Earnings Growth & PFE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.93 per share, an increase next quarter of $0.06 per share, an increase this year of $1.11 per share, and an increase next year of $0.22 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.02 per share, an increase next quarter of $2.76 per share, an increase this year of $4.40 per share, and an increase next year of $8.97 per share.

Pfizer Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):